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Abstract
Next-generation RNA sequencing (RNA-seq) maps and analyzes transcriptomes and generates data on sequence variation in
expressed genes. There are few reported studies on analysis strategies to maximize the yield of quality RNA-seq SNP data.
We evaluated the performance of different SNP-calling methods following alignment to both genome and transcriptome by
applying them to RNA-seq data from a HapMap lymphoblastoid cell line sample and comparing results with sequence
variation data from 1000 Genomes. We determined that the best method to achieve high specificity and sensitivity, and
greatest number of SNP calls, is to remove duplicate sequence reads after alignment to the genome and to call SNPs using
SAMtools. The accuracy of SNP calls is dependent on sequence coverage available. In terms of specificity, 89% of RNA-seq
SNPs calls were true variants where coverage is .10X. In terms of sensitivity, at .10X coverage 92% of all expected SNPs in
expressed exons could be detected. Overall, the results indicate that RNA-seq SNP data are a very useful by-product of
sequence-based transcriptome analysis. If RNA-seq is applied to disease tissue samples and assuming that genes carrying
mutations relevant to disease biology are being expressed, a very high proportion of these mutations can be detected.
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Introduction
The transcriptome consists of all RNA transcripts, coding or
non-coding, expressed within a given cell or tissue. Its annotation
and quantification has been the subject of extensive investigation
for several decades. Studying the transcriptome in disease tissue
can give important insights into the functional properties of
specific RNA transcripts and thereby provide a clearer under-
standing of the underlying disease processes.
Until very recently the predominant means of studying the
transcriptome was using hybridisation based methods such as
microarrays [1]. These however are not without limitations;
difficulties in monitoring the efficiency of probe hybridisation,
cross hybridisation as a result of repetitive regions and issues
relating to the normalisation of transcript levels in relation to
transcript abundance are common. Probe design is inherently
based on known sequences therefore limiting the extent of novel
gene/transcript and splice discovery that is possible, although
tiling microarrays are now available [2].
Next generation sequencing technologies have rapidly changed
transcriptome analysis as researchers acknowledge the benefits of
RNA sequencing (RNA-seq). This methodology, which allows the
direct sequencing of cDNA libraries, allows for more accurate
quantification of RNA transcripts in a given cell or tissue [3] but
importantly requires no prior sequence knowledge thereby
allowing the discovery of new genes, transcripts, alternative splice
junctions, fused sequences and novel RNAs [4]. RNA-seq has
been used to examine differential gene expression for different
genes and tissues [5] but has also been applied to the study of
allelic differences in expression [6,7] transcriptome characterisa-
tion [8,9] analysis of RNA-protein interactions [10] and analysis of
alternative splicing [11].
RNA-seq can be performed on RNA extracted from disease
tissue or blood directly obtained from an individual. For a large
number of disease studies it has become increasingly common to
generate lymphoblastoid cell lines (LCLs) for patient samples using
EBV transformation of blood lymphocytes. This not only provides
an unlimited source of patient DNA but gives researchers a
valuable source of RNA to use for gene expression/functional
studies [12] and many large-scale LCL repositories now exist.
LCLs have been shown to be a reliable source material for SNP
genotyping in genomic DNA [13] and studies of genetic variation
in gene expression [14]. The Welcome Trust Case Control
Consortium have successfully performed genome-wide association
studies (GWAS) using SNPs and copy number variation (CNVs)
for eight diseases using a common control panel where half of the
3,000 control DNA samples were derived from LCLs [15,16].
Whilst expression results generated in cell lines should be
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interpreted with caution, some recent studies have supported the
use of human lymphocytes as a good cellular model for gene
expression in other tissues [17–19] and there is evidence that
expression quantitative trait loci detected in LCLs can overlap
with those found in relevant tissues [20].
As with transcriptome analysis, array-based genome-wide
analysis of DNA sequence variation is being superseded by next-
generation sequencing, which offers the opportunity to detect all
variants present and not just assay the variants targeted by pre-
designed arrays. Whole-genome sequencing is being applied in the
1000 Genomes (http://www.1000genomes.org/) project to ex-
pand on resources such as HapMap to include rare variation [21].
This is particularly important for researchers studying complex
diseases as, for many disorders, a substantial proportion of their
heritability may be a result of rare variants in the form of SNPs,
indels or CNVs [22].
While whole genome sequencing remains costly for disease
genetics, an intermediate option is exome sequencing [23] on the
premise that the majority of disease related mutations are located
within coding sequences (approximately 1–2% of the genome).
From Mendelian disease we know that mutations causing amino
acid changes account for ,60% of disease mutations [24]. While
RNA-seq is primarily considered a method of gene expression
analysis, it is also a form of exome sequencing with the capacity to
detect sequence variation in those genes that are expressed in the
sample. Therefore, a major advantage of RNA-seq is to offer a
convergent approach to disease research by providing information
for gene expression/characterisation and also coding sequence
variation plus potential insight into post translational processes
such as RNA editing.
A number of studies have reported on the viability of SNP
detection using RNA-seq[7,25–31] but the purpose of this study is
to determine the best approach for RNA-seq SNP analysis by
evaluating the performance of different alignment strategies and
SNP-calling methods in comparison to extensive available online
sequence variation data such as 1000 Genomes data. To do this
we calculate the specificity and sensitivity of RNA-seq SNP
detection. Specificity addresses the question: how likely is a SNP
detected by RNA-seq to be a true variant in the DNA sequence?
Sensitivity addresses the question: how likely is RNA-seq to detect
an expressed SNP if it is present in a transcribed gene? Overall the
results indicate that RNA-seq is a very accurate method of SNP
detection. Where genes are strongly expressed, a high proportion
of coding SNPs will be correctly identified.
Materials and Methods
Sample Preparation and RNA Sequencing
Total RNA was extracted from the HapMap CEU lympho-
blastoid cell line sample (Coriell Institute for Medical Research) for
individual NA12878 using Qiagen’s RNeasy mini kit. Illumina
sequencing libraries were prepared according to the Illumina
mRNA Sequencing Sample Prep Guide (1004898 Rev. D). Briefly,
poly-A-containing molecules were purified and fragmented,
followed by double-stranded cDNA synthesis. The resulting
double-stranded cDNA was end-repaired before ligation of
Illumina-specific adaptors and finally was PCR enriched. Se-
quencing was carried out on an Illumina Genome Analyzer II to
produce three lanes (A–C) of 40 bp single-end reads (lane
A= 11,683,367, lane B= 13,980,330 and lane C=15,120,659
reads) see table S1). Data from lanes A, B and C combined to
create the test sample dataset (40,784,356 reads). This RNA-seq
data for sample NA12878 has been deposited in the Short Read
Archive (http://www.ncbi.nlm.nih.gov/sra; SRA065878). In ad-
dition to generating data in-house on NA12878, we accessed
RNA-seq data for HapMap samples NA12891 (80,062,322 reads)
and NA12892 (80,023,135 reads) from the Short Read Archive
(SRR074943, SRR074953). In order to compare these data to our
in-house data, we trimmed the reads for these two samples to a
length of 40 bp.
Analysis Strategy and Methods
Figure 1 gives an overview of the 8 analysis strategies and
methods that we employed to identify the best performing
methods of RNA-seq SNP detection. Strategies are outlined in
detail below but in brief this involved removing duplicate reads
pre- and post-alignment to either the genome or transcriptome
and the use of two different SNP callers.
Duplicate Reads
The first decision was if and when to remove identical
duplicate reads from analysis. Duplicate reads in sequence data
can occur during the PCR/library preparation steps, from
sequencing artefacts such as poly-A and poly-N reads, noise in
cluster detection and from cDNA fragmentation at the same
location in different molecules [32]. This can lead to an
exaggeration of coverage levels and impact the accuracy of
variant calls. To avoid this, where duplicate reads are detected,
only one copy of the read is kept and duplicates are generally
removed either pre- or post-alignment. The difference between
pre- and post-alignment strategies is as follows: Duplicate reads
dropped pre-alignment have exact identical sequence whereas
those dropped post-alignment are reads that map to the same
position in the genome or transcriptome, i.e. have the same
start and end coordinates, but can contain sequence differences
internally. There is no gold standard method to deal with
duplicates. Removal of duplicates pre-alignment will miss
duplicate reads that are derived from the same cDNA fragment
but contain sequencing errors, therefore resulting in an
underestimation of duplicate reads. Removal of duplicates
post-alignment could exclude a read containing the second
allele of a SNP and thus will result in loss of valuable
information. To determine the best method of dealing with
duplicates we analyzed our data by removing duplicates pre-
alignment (strategy A) and post-alignment (strategy B) and
studied the impact on the number and quality of SNP calls.
Table S1 details the number of duplicate reads detected for
each sample.
Alignment and SNP Calling
Tophat version 1.4.1 was selected for alignment of the
generated RNA-seq reads with two mismatches allowed per
uniquely aligned read. We wanted to compare SNP calls
generated when aligning reads to the reference genome compared
to a transcriptome-only approach and therefore each sample was
aligned using both duplicate read methods to the reference
genome (NCBI build 36.1) and to the associated refFlat gene list
from UCSC, which represents the transcriptome (see figure 1). In
addition, two different publically available SNP calling softwares
were used; SAMtools v-1.18 [33] and GATK (Genome analysis
toolkit (v-1.0.5506) [34], both of which used in the analyses of data
from the 1000 Genomes project(21).
To summarize, eight different variant calling strategies were
carried out. In strategy A, identical sequences were removed pre-
alignment and the remaining reads were aligned to both a
transcriptome reference and a whole genome reference. Two SNP
callers were then applied to the alignment files generated, resulting
in four different variant call sets for strategy A: pre_trans_sam and
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pre_trans_gatk are the call sets generated following alignment to
the transcriptome alone and pre_genome_sam and pre_genome_-
gatk are the corresponding files generated following whole genome
alignment. Strategy B follows an identical protocol except the
removal of duplicate reads post-alignment to the relevant
reference. Similarly four variant call sets were generated for this
strategy: post_trans_sam and post_trans_gatk following transcrip-
tome alignment and post_genome_sam and post_genome_gatk
from the genome alignments. The sensitivity and specificity of
each SNP was assessed by the number of reads aligned at each
individual base (providing this was greater than 36 coverage).
SAMtools derived SNP calls were generated with default pileup
settings and standard SNP filters. GATK derived SNP calls were
filtered using standard GATK SNP filters. All calls were
subsequently filtered to remove sites overlapping regions where
no variant calls were attempted in the 1000 Genomes pilot study 2
[21]. SNP calls generated by SAMtools and GATK were finally
filtered to remove SNP clusters, where two or more variants
occurred in a three base-pair window. SNP calls passing filtering
were examined for concordance with the 1000 Genomes release
from March 2010 (http://browser.1000genomes.org/index.html),
and dbSNP build 132.
RNA-seq reads are sampled from a gene in a manner
proportional to its expression level in a given tissue. As a result,
the coverage of variants varies greatly from gene to gene. In
addition, mapping efficiency of individual nucleotide sites is
dependent on a number of variables including regional GC
content and uniqueness, and means that non-uniform base
coverage across a gene or exon can occur, which will influence
SNP discovery. As a consequence the definition of each gene in the
transcriptome as expressed or not expressed based on median or
mean base coverage per exon [26] is a poor proxy for defining the
ability to call SNPs at any individual base in a gene. In this study
we estimated the coverage in our sample at each site of the
published 1000 Genomes variants and calculated our ability to
correctly call these sites as variant in RNA-seq data at different
sequencing depths. For individual NA12878, the 1000 Genomes
pilot 2 study predicted a total of 2,766,610 SNPs of which 45,371
occurred within boundaries of the 23,147 genes defined as the
transcriptome in this study. For NA12891, there were 2,720,364
SNPs of which 44,462 were genic and for NA12892, there were
2,736,863 SNPs of which 45,437 were genic.
Calculation of Specificity and Sensitivity
The different metrics of RNA-seq SNP detection that we
wanted to measure were the number of SNPs called per sample
and the specificity and sensitivity of those SNP calls. The 1000
Genomes pilot study 2 SNP calls were used to determine the
accuracy of calls made using RNA-seq data. All 1000 Genomes
variant sites with .=3X coverage in our data were treated as
expected calls for this individual and used to define both the
specificity and sensitivity of cDNA derived variant calls. Specificity
was calculated as the number of true positives divided by the
number of true positives plus the number of false positives. A true
positive was any SNP present in our sample data and the
corresponding 1000 Genomes and/or dbSNP data that had the
correct genotype or in the case of dbSNP had the expected alleles
at that position. A false positive SNP call is where the genotype in
our data did not match 1000 Genomes data or the variant was not
present in dbSNP. As we were dealing with transcriptome data as
opposed to full genome data this meant that we will only be able to
detect SNPs at sites expressed in our samples. To perform
sensitivity analysis we calculated the number of true positives
divided by the number of true positives plus the number of false
negatives. A true positive was where we detected the expected
genotype and a false negative is where we either did not detect a
Figure 1. Analysis strategies and methods for RNA-seq SNP detection. This figure outlines the analysis strategies and methods used to
identify the best performing methods of RNA-seq SNP detection. We analyzed our data by removing duplicates pre-alignment (strategy A) and post-
alignment (strategy B). Reads were aligned to either the genome or the transcriptome and SNP calls generated using SAMtools and GATK. This
produced 8 sets of calls for analysis (see table S2a).
doi:10.1371/journal.pone.0058815.g001
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SNP at that position, or did detect a SNP but the genotype did not
match.
SNPs identified in our RNA-seq data for which no correspond-
ing variant was reported in the 1000 Genomes pilot study release
were further examined in both dbSNP132 and the publicly
available 1000 Genomes alignment (BAM) files. SNPs with a
matching position and identical alternative allele call in dbSNP
were considered as potentially true variants. In addition,
corroborating evidence for the RNA-seq variant call was
examined in the 1000 Genomes alignment files because not all
true variants will have passed the filters employed in that study.
For heterozygote calls we required the alternative allele to occur in
between 20 and 80% of the 1000 Genomes aligned reads to
provide potential evidence of a true variant occurring at a site. For
homozygote non-reference calls we required .90% of reads in the
1000 Genomes alignment to carry the predicted alternative allele
at a site.
Results
The overview figure 1 demonstrates the analysis strategy that we
employed to evaluate RNA-seq as a SNP detection tool. We
initially applied these methods to our in-house RNA-seq data for
NA12878 and the results of these analyses using all methods based
on all strategies in figure 1 are detailed in table S2. We
subsequently validated these methods using additional online
RNA-seq data for NA12891 and NA12892, and describe these
analyses at the end of the results section.
Gene/Exon Expression in the NA12878 LCL Sample
The hg18 refFlat gene set of 23,147 unique genes is composed
of 212,392 exons. Aligning 40,784,356 single-end 40 bp fragments
resulted in at least one sequence read mapping to 17,014 genes
and 139,143 exons. 82,091 exons had complete coverage at 16or
greater across their full length. The 23,147 genes in the refFlat
gene set span 67,893,145 base pairs in the hg18 genome release.
Consistently across all alignment methods employed here, 50% of
these bases were not covered by a single read and 12% of the bases
in the transcriptome have 1–26coverage. The remaining 38% of
sites had 36or greater coverage and represent the total number of
transcriptome spanning sites at which a genotype call was
attempted in this study.
SNP Calls
Figure 2 displays (a) the number of SNPs called for each of the
eight methods employed for NA12878. SAMtools consistently
identifies 8–10% more variants than GATK for each of the
alignment methods. Approximately 96% of these extra SAMtools
variants are called at coverages lower that 106and most likely are
a consequence of the differing post-calling filtering strategies
employed by the two variant calling pipelines. Alignment to the
transcriptome identified between 12,296 and 14,224 variants
depending on the SNP caller and duplicate read removal strategy.
This represents between 27 and 33% of the total expected number
variants in the transcriptome of individual NA12878 based on
1000 Genomes pilot study 2. Between 80 and 88% of these called
variants are identified at sites reported by the 1000 Genomes study
and have an identical genotype assignment. Overall, for approx-
imately 70% of 1000 Genomes transcriptome-overlapping SNPs a
read depth of at least 36was not generated in this study and no
genotype call was attempted. On average for each transcriptome-
only calling method, 50–57% of the 45,371 known sites had zero
reads overlapping and represent sites in genes unexpressed in LCL
or sites in expressed genes where non-uniformity of coverage
across the transcript renders sites unusable. Whole genome
alignment identifies between 15,213 and 19,683 SNPs depending
on the method employed. The additional SNPs generated from
genome alignment, when compared to the transcriptome only
alignment calls, occur in regions outside those annotated as exonic
in RefSeq gene annotations. Table S2 details the number of SNPs
detected for the different methods at varying degrees of coverage.
Specificity
The specificity of NA12878 SNP calls based on 1000 Genomes
data for each of the eight methods at varying coverage depths are
displayed in figure 3A. At all read depths removal of duplicate
reads post-alignment (broken lines) results in a higher degree of
specificity than removal of duplicate reads pre-alignment. Even at
depths as low as 36, .60% of predicted variants represent real
1000 Genomes SNPs with specificity increasing to .90% at sites
with .=106 coverage. A consistent finding for all methods was
that the specificity reached a plateau when base coverage is.10X.
These data indicate that a very high proportion of SNPs detected
in RNA-seq data are true variants and as expected the likelihood
of an accurate SNP call increases with higher sequence coverage.
The specificity of SNP calls is very similar for both heterozygous
and homozygous sites (figure 4A).
For each of the calling strategies we noted a substantial number
of sites which had not been identified as variant in the available
1,000 Genomes data (Table S2). Although these SNPs had been
classified false positive results in our specificity analysis, some may
represent variants that have not previously been recorded in
analysis of this individual by 1000 Genomes as a result of
insufficient coverage or being outside the employed variant
filtration parameters at these particular loci in the sequence data.
In order to quantify what proportion of these variants may
potentially be true, we accessed the aligned BAM files from the
Figure 2. Number of SNPs per method in RNA-seq data. This
figure displays the number of SNPs called for each of the 8 methods
used. The proportion of heterozygous (grey) and homozygous (black)
SNP calls is also displayed. Details of the numbers of SNPs called are
listed intable S2a.
doi:10.1371/journal.pone.0058815.g002
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1000 Genomes at these loci and looked for evidence of a non-
reference allele(s). The number of RNA-seq variant calls for which
acceptable evidence of variation is present in the aligned 1000
Genomes data ranges between 5 and 8% indicating that a small
but appreciable proportion of these variants may represent true
SNPs within the our data that were not detected to date by 1,000
Genomes project analysis (Table S2). A slightly higher proportion
of these SNPS are also found in dbSNP132 but most represent
SNPs deposited there as part of the three 1000 genomes pilot
studies (Table S2).
Sensitivity
To perform sensitivity analysis we identified SNPs that had
known genotypes from 1000 Genomes data for NA12878 and
were located at sites covered by at least 3 reads in our RNA-seq
data. Figure 3B shows the sensitivity for each method for the
sample. Similar to the specificity analysis, at all read depths
removal of duplicate reads post-alignment (broken lines) results in
a higher degree of sensitivity than removal of duplicate reads pre-
alignment. For all calling strategies sensitivity ranges from 40% to
80% at coverage depths below 106. In this coverage range,
sensitivity is much higher for homozygous variants compared to
heterozygous variants (figure 4B). Above 106, all methods
converge at approximately 92% sensitivity (figure 3B), indicating
that a very high proportion of expected variants will be detected
using RNA derived reads if sufficient coverage is available.
Extension of Analyses to NA12891 and NA12892
To investigate if the results from our analyses were reproducible
when applied to other RNA-seq datasets, we applied the same
methods of SNP detection to online RNA-seq data for NA12891
and NA12892. Importantly, these two samples have also been
whole genome sequenced to a deep coverage by 1000 Genomes so
two comprehensive sets of SNP calls are available to compare
against our SNP calls from the RNA-seq data. As methods
employing the removal of duplicate reads post-alignment per-
Figure 3. Specificity and sensitivity of the SNP calls from RNA-
seq data. This figure displays the specificity (A) and sensitivity (B) of
the SNP calls for each of the 8 methods at a range of coverage depths.
Solid lines represent calls made where duplicate reads had been
removed pre-alignment and broken lines are calls generated when
duplicate reads are removed post-alignment.
doi:10.1371/journal.pone.0058815.g003
Figure 4. Specificity and sensitivity of heterozygous and
homozygous SNP calls from RNA-seq data. This figure displays
the specificity (A) and sensitivity (B) for heterozygous and homozygous
SNP calls for the post_genome_gatk calling method at a range of
coverage depths.
doi:10.1371/journal.pone.0058815.g004
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formed best for our in-house sample, we just present data from
these four methods for the two online samples.
More sequence reads were available for these two samples
(80,062,322 and 80,023,151 reads for NA12891 and NA12892
respectively) compared to our in-house sample (40,784,356 reads).
When aligning to transcriptome, SNP numbers are similar in all
three samples for all calling methods tested (table S2a, b, c; figure
S1). However, when we align to the genome, we note firstly that
the results for the two on-line samples are very similar (average of
67,647 SNPs called per sample using SAMtools) but secondly we
note that this SNP number is far greater than we called for our in-
house sample (16,455 SNPs; figure S1). Analysis of the aligned
reads indicates that the proportion of reads aligning to the
annotated transcriptome is very different between our in-house
sample (95%) compared to the two online samples (45%). Thus,
when we align this data to the genome, the extra reads mapping
off-transcriptome are generating a huge increase in SNP calls in
the online sample data. This outcome could be due to differences
in the sample prep protocols employed for the different samples, in
particular in relation to Poly-A purification, which does influence
the comparability of RNA-seq datasets [35].
When we calculate specificity and sensitivity across our range of
methods, we find that the results for the two online samples are
near identical (figures S2, S3, S4, S5; table S2b,c). This highlights
the reproducibility of the SNP calling methods when applied two
RNA-seq datasets that were generated using the same methods.
When removing duplicate reads post-alignment, specificity is best
at all coverage levels when aligning to the genome compared to
the transcriptome and there is little difference in performance
between GATK and SAMtools (e.g., both 85% specificity at 106
coverage for genome). Sensitivity is marginally better for genome-
compared to transcriptome-alignment and SAMtools slightly out-
performs GATK at all read depths above 106 (e.g., 89% versus
88% sensitivity at 106coverage for genome). As SAMtools is also
calling more variants to begin with, it appears to be the better SNP
caller for RNA-seq data. When we compare the specificity and
sensitivity measurements for the two online samples to those from
our in-house NA12878 sample, we do observe some differences
but mostly for SNPs called at lower coverage levels (figure 5; table
S2a, b, c). Above 106 coverage, the data is much less noisy,
especially for the sensitivity measurements.
Discussion
This study examined next-generation transcriptome sequencing
(RNA-seq) as a method of expressed SNP detection in LCLs.
Many disease samples are now biobanked as LCLs and RNA from
these cell repositories are routinely used for scientific investigation.
As well as data on expression and splicing, RNA-seq data can be
used for SNP detection. It is therefore important to determine the
best strategy for RNA-seq SNP analysis and we have addressed
this question by quantifying the specificity and sensitivity of
different alignment and SNP-calling methods. These results are
also relevant to non-LCL derived RNA, e.g. from a different cell
line type or from a disease tissue sample, because they inform on
the parameters required for accurate SNP calling in RNA-seq
data.
We explored different strategies for RNA-seq SNP detection by
dropping duplicate sequence reads either pre- or post-alignment
and using different reference data for alignment (genome and
transcriptome) and different SNP-calling algorithms (SAMtools
and GATK; figure 1). We note that removing duplicate reads post-
alignment confers an appreciable increase in SNP detection in
terms of specificity and sensitivity when compared to dropping
reads pre-alignment. These differences are more pronounced at
read depths below 106 and indicate how marking of PCR
duplicates after alignment is more sensitive to removal of reads
originating from the same genome location which contain a
sequencing error rather than evidence of a true mismatching base,
when compared to strategy that collapses identical reads pre-
alignment.
The major difference between results of SNP-calling based on
alignment to the transcriptome or the genome was the number of
SNPs identified rather than the specificity or accuracy of those
SNP calls. Whole genome alignment results in more calls across all
methods when compared to alignment to the transcriptome alone.
Specificity and sensitivity measurements are at least similar and
often better for the genome alignment methods compared to the
transcriptome alignment methods. Several widely used gene sets
for the human genome have been generated including RefSeq
(taken from the NCBI RNA reference sequences), ENSEMBL
(computationally predicted from genomic sequence) and UCSC
Figure 5. Specificity and sensitivity of the SNP calls from RNA-
seq data for all three samples. This figure displays the specificity (A)
and sensitivity (B) of the SNP calls for each of the three samples (in
colour) at a range of coverage depths using the post_genome_sam
method. The black lines plot the averages of all three samples plus 95%
confidence intervals.
doi:10.1371/journal.pone.0058815.g005
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(based on protein data from Swiss-Prot/TrEMBL (UniProt) and
the associated mRNA data from Genbank). Each of these gene sets
contains significant differences from the others with both the
RefSeq and UCSC datasets being more conservative than the
ENSEMBL predictions. Even allowing for the differences between
these three datasets, a significant proportion of the SNPs called
following alignment to the genome occur in regions outside any
annotated gene region and would be missed by any analysis using
the transcriptome alone. This finding is of particular relevance to
variant calling studies in organisms without a fully sequenced
genome. Transcriptome de novo assembly followed by variant
detection in such species could result in a considerable underes-
timation of expressed variants, unless the transcriptome is
generated from reads sourced from all tissues. Sequencing to
sufficient depth to completely reconstruct the transcriptome of
such a species would be prohibitively expensive and with advances
in sequencing technology it might be more economical to
sequence the genome of such species to use as a reference for
subsequent RNA related studies.
Significant overlap exists between the calls sets generated by the
two SNP callers used in this study. On average 98% of GATK
derived calls are found in the SAMtools call set generated on the
same alignments, while approximately 91.5% of SAMtools calls
overlap with those of GATK, reflecting the higher number of SNP
calls by SAMtools. Comparison of results for both calling strategies
employed in this study indicates that sensitivity and specificity
calculations for variant calls made at.=106coverage using both
SAMtools and GATK are virtually identical (figure 3). At coverage
depths below 106, SAMtools displays a higher degree of sensitivity
but a slightly lower specificity when compared to GATK. This is
because at these coverage levels, the greater number of SNPs
called by SAMtools identifies a higher proportion of the expected
true variants (increasing sensitivity) but with an associated increase
in the number of false positive SNP calls (reducing specificity).
Cirulli et al. [26] investigated the specificity of RNA-seq as a
SNP detection method by comparing whole genome and whole
transcriptome sequence for one individual. RNA was sourced from
peripheral blood mononuclear cells (PBMCs). When they restrict-
ed their analysis to PBMC-expressed genes; they report a
specificity of 67%, which is much lower than the specificity
reported here. This result was based on 8 lanes of sequence data
and they report that specificity dropped as the quantity of
sequence data used in the analysis increased. When this study used
just one lane of sequence data (equivalent to our study), specificity
was calculated as 83%; a result closer to the levels we report here.
In our study we had the benefit of being able to compare our
RNA-seq data to a more complete catalogue of genomic variation
data, which is likely to result in more accurate specificity
calculations. In addition, we utilised the masking data generated
by the 1000 Genomes project to remove sites from our analysis at
which variants cannot confidently be called. The addition of this
step to the pipeline significantly reduces the number of false
positive from the SNP call sets. In the absence of this step the
specificity and sensitivity estimated for our SNP calls closely
mirrors the results generated in previous studies [26]. For the three
CEU individuals sequenced as part of the 1000 Genomes pilot
study the ‘‘inaccessible’’ genome was estimated at 20% of total
bases (decreasing to 15% in coding regions) [21]. The majority of
these regions were removed from any variant calling analysis in
that study due to difficulty in accurately mapping reads to these
parts of the genome, as they mainly represent high-copy repeats or
segmental duplications. Of particular relevance to RNA-seq is that
more than 25% of human RefSeq genes contain at least 10% of
non-unique sequence [36]. This is principally due to the high rate
of gene duplication in mammalian gene families as well as the
widespread presence of common functional domains amongst
even non-related genes. The presence of such non-unique regions
in genes has important consequences for normalisation steps in
RNA-seq derived expression studies and, as shown here, using
information on non-unique gene regions will help reduce the
number of false positive SNP calls in RNA-seq data.
Genome mappability is influenced by both the local genomic
content and the sequencing strategy employed. A recent study has
produced an algorithm for determining the mappability of each
base in any reference genome using a user-specified read length
and mismatch number [37]. Using this method we were able to
generate mappability data matching to the read length and
number of sequence mismatches selected in alignment of our RNA
data. SNPs excluded from our analysis using this in-house
generated mappability data almost identically mirrors the sites
excluded using the 1000 Genomes accessible genome information
(data not shown). Use of such a mappability profile, generated with
the appropriate length and mismatch criteria, must be incorpo-
rated into any RNA-seq variant calling study in order to minimise
the number of spurious calls generated.
What is the cause of false positive SNP calls in our data? The
majority of these discordant genotypes occur at sites of ,106
coverage (figure 5). At .106 coverage, the proportion of these
mis-matches drops to ,12% for pre-alignment duplicate removal
strategies and ,6% when duplicates are removed post-alignment.
For NA12878, a small number of our false positive SNP calls were
in fact true variants when we examined alignment data from 1000
Genomes indicating that the exhaustive genomic sequencing of
this sample may not yet have identified all variants present in this
individual.
Our sensitivity analysis addressed the issue of what proportion
of true variants will be detected in a RNA-seq SNP analysis. This
again very much depends on coverage of the site irrespective of the
overall quantity of data produced for a test sample. For all analysis
methods tested here, overall sensitivity is .90% when there is
.10X coverage but can drop as low as 40% if a site has 36
coverage. As expected, the majority of false negative sites in our
RNA-seq sample occur at heterozygous sites where we have low
coverage (figure 4B). At such sites sufficient evidence for the
alternative allele may not be present in order to confidently emit a
non-reference call. The reduction of the false-negative rate to
,5% above 106 coverage suggests that sequencing to a higher
depth should decrease this rate appreciably.
There are a number of additional factors that affect both
sensitivity and specificity. All calculations in this study are based on
1000 Genomes data being correct. Comparison of available
HapMap and 1000 Genomes data for sample NA12878 identified
1,964,991 SNPs common to both datasets; however genotypes did
not match for 2% of these SNPs. Other factors to consider are
errors in the RNA-seq data (sequencing errors or artefacts of the
EBV cell line transformation), allelic imbalance in the RNA,
random mono-allelic expression in clonal cell lines [38], or
instances of RNA editing. The majority of sequencing errors
should be filtered out providing the sequence/base quality is high
enough but it is not possible to exclude all errors. Allelic expression
differences in the RNA whereby one allele at an expected
heterozygous site is over-expressed and appears as a homozygote
would result in a mis-match genotype call between DNA and
RNA. RNA-seq has been used in several studies for the
identification of these sites[7,39–41]. RNA editing is a post-
transcriptional mechanism of base re-coding through insertion,
deletion or modification of nucleotides and has been associated
with a number of diseases, including several neurological disorders
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[42,43]. We do not believe RNA editing to have a major influence
on SNP calling in our study because only 0.4% of our false
negative calls occurs at known sites of RNA editing ([44]; data not
shown).
We have shown that accurate variant detection is possible using
cDNA derived sequencing reads at sites with .106 coverage. In
our study of a LCL sample, SNP calling was possible at 38% of the
annotated transcriptome. The prohibitive cost associated with
sequencing to the required depth, to accurately call all expressed
variants in a sample, means that while RNA-seq variant calling
works well, it is not a viable alternative to exome or whole genome
sequencing. Use of longer and/or paired-end reads will increase
the base coverage within expressed genes in a sample and as a
result increase the sensitivity of the SNP calls generated, but this
will be limited to SNPs occurring in relatively highly expressed
genes.
In conclusion, SNP calls in RNA-seq data is a useful by-product
of the technique and boosts the amount of data that can be
generated from such experiments and potentially used in
convergent functional genomics research. We found that in
addition to the computational benefit of reducing the number of
reads to be processed in downstream steps, removing duplicate
sequences post-alignment will increase the quality SNPs called
overall. We found that aligning sequence reads to a genomic
rather than transcriptomic reference will increase the number of
SNPs called, with the additional SNPs occurring at bases not
currently curated as genic regions in human genome annotation
sets and greater specificity is achieved when aligning to the
genome. SAMtools identifies 8–10% more variants that GATK
and thus detects more true SNPs than GATK (higher sensitivity)
but also calls more false positives than GATK at low coverage
(lower specificity). When we applied our methods to multiple
RNA-seq datasets that had being prepared and sequenced with the
same methods (online samples NA12891 and NA12892), the
results for metrics of SNP detection were very reproducible. When
we compared these data to our original in-house sample
(NA12878), the main difference was the overall number of SNPs
detected. This indicated that the number of sequence reads used in
an analysis and original preparation of the sequencing library will
influence SNP detection. Despite this large difference in SNP
number, the only differences of note between the samples were
found at lower coverages. At .106 coverage, specificity and
sensitivity were very similar, again highlighting the reproducibility
of the methods. Overall, using appropriate methods and filters, a
very high proportion of SNPs called in RNA-seq data will be true
variants and RNA-seq SNP analysis will identify the majority of
variants present in expressed exons provided sufficient coverage is
available.
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